Abstract
17α-Hydroxylase deficiency (17OHD) is a rare form of congenital adrenal hyperplasia caused by mutations in the CYP17A1 gene. This condition shows considerable clinical and biochemical variation. Molecular characterization of novel mutations in the CYP17A1 gene and detailed study of their structural, enzymatic, and clinical consequences are required to fully understand enzyme behavior. Here, we present the first molecular characterization of two novel mutations in CYP17A1 in a 15-year-old female Mexican mestizo 46,XY female with primary amenorrhea and lack of pubertal development and severe hypertension that manifested only after surgery. A complete clinical and biochemical evaluation was compatible with 17OHD. Structural anomalies in the CYP17A1 gene were discovered by direct automated sequencing, which revealed a novel compound heterozygous K110X/R362H mutation that leads to a complete lack of enzyme activity. Immunohistochemical analyses performed to determine protein expression and localization showed that cytochrome P450 17A1 was completely absent in the patient’s testicular tissue. Studies of novel mutations, such as those described here, provide important information that allows us to better understand the effect of a given mutation on enzyme function and to observe the impact of the mutation on clinical phenotype.
This is a preview of subscription content, log in via an institution to check access.
References
Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, Timmerman MA, et al. Differential Inhibition of 17b-Hydroxylase and 17,20-Lyase Activities by three novel missense CYP17 mutations Identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 87:5714–5721, 2002.
New MI. Male pseudohermaphroditism due to 17alpha-hydroxylase deficiency. J Clin Invest 49:1930–1941, 1970.
Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North America 30:101–119, 2001.
Di Cerbo A, Biason-Lauber A, Savino M, Piemontese MR, Di Giorgio A, Perona M, et al. Combined 17alpha-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J Clin Endocrinol Metab 87:898–905, 2002.
Katsumata N, Satoh M, Mikami A, Mikami S, Nagashima-Miyokawa A, Sato N, et al. New compound heterozygous mutation in the CYP17 gene in a 46, XY girl with 17alpha-hydroxylase/17,20-lyase deficiency. Horm Res 55:141–146, 2001.
Lam CW, Arlt W, Chan CK, Honour JW, Lin CJ, Tong SF, et al. Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17alpha-hydroxylase deficiency. Mol Genet Metab 72:254–259, 2001.
Takeda Y, Yoneda T, Demura M, Furukawa K, Koshida H, Miyamori I, et al. Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency. Clin Endocrinol (Oxf) 54:751–758, 2001.
Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 17:201–205, 1997.
Yanase T, Simpson ER, Waterman MR. 17alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91–108, 1991.
Costa-Santos M, Kater CE, Auchus RJ. Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hidroxylase deficiency. J Clin Endocrinol Metab 89:49-60, 2004.
Won GS, Chiu CY, Tso YC, Jenq SF, Cheng PS, Jap TS. A compound heterozygous mutation in the CYP17 (17alpha-hydroxylase/17,20- lyase) gene in a Chinese subject with congenital adrenal hyperplasia. Metabolism 56:504-507, 2007.
Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, Villar H, Longui CA, Mendonca BB. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88:5739-5746, 2003.
Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, et al. Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 91:3619-3625, 2006.
Müssig K, Kaltenbach S, Machicao F, Maser-Gluth C, Hartmann MF, Wudy SA, et al. 17α-Hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 Gene. J Clin Endocrinol Metab 90:4362-4365, 2005.
Miura K, Yasuda K, Yanase T, Yamakita N, Sasano H, Nawata H, et al. Mutations of cytochrome P-45017 alpha gene (CYP17) in Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 81: 3797-3801, 1996.
Wei JQ, Wei JL, Li WC, Bi YS, Wei FC. Genotyping of five Chinese patients with 17α-hydroxylase deficiency diagnosed through high performance liquid chromatography serum adrenal profile: Identification of two novel CYP17 mutations. J Clin Endocrinol Metab 91:3647-3653, 2006.
Bhangoo A, Aisenberg J, Chartoffe A, Ten S, Wallerstein RJ, Wolf R, Auchus RJ. Novel mutation in cytochrome P450c17 causes complete combined 17alpha-hydroxylase/17,20-lyase deficiency. J Pediatr Endocrinol Metab 21:185-190, 2008.
Riepe F, Tatzel S, Sippell WG, Pleiss J, Krone N. Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice. Endocrinology 146:2563-2574, 2006.
Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17 alphahidroxylase/17,20-lyase: insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13:1169–1182, 1999.
Fardella CE, Zhang LH, Mahachoklertwattana P, Lin D, Miller WL. Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17alpha-hydroxylase deficiency. J Clin Endocrinol Metab 77:489–493, 1993.
Imai T, Yanase T, Waterman MR, Simpson ER, Pratt JJ. Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet 89: 95-96, 1992.
Chen Y, Belleamy WP, Seabra MC, Field MC, Bassam EA. ER-associated protein degradation is a common mechanisms underpinning numerous monogenic disease including Robinow syndrome. Hum Mol Genet 14:2559-2569, 2005.
Ishii S, Chang H, Kawasaki K, Yusuda K, Wu H, Garman S, Fan JQ. Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimcycin. J Biochem (Tokyo) 406:285-295, 2007.
Gallagher M, Ding L, Maheshwari A, Macdonald R. The GABAa receptor α1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteosomal degradation. Proc Natl Acad Sci USA 104:12999-13004, 2007.
Acknowledgments
This work was supported by grants from the Research Division of the Hospital General de México, CONACYT (48017), and the Universidad Nacional Autónoma de México DGAPA (IN225608-3 UNAM)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nájera, N., Garibay, N., Pastrana, Y. et al. Loss of Cytochrome P450 17A1 Protein Expression in a 17α-Hydroxylase/17,20-Lyase-Deficient 46,XY Female Caused by Two Novel Mutations in the CYP17A1 Gene. Endocr Pathol 20, 249–255 (2009). https://doi.org/10.1007/s12022-009-9088-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-009-9088-9